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Abstract
Objectives Recent studies suggest that a combination of
enamel matrix derivative (EMD) with grafting material may
improve periodontal wound healing/regeneration. Newly de-
veloped calcium phosphate (CaP) ceramics have been dem-
onstrated a viable synthetic replacement option for bone
grafting filler materials.
Aims This study aims to test the ability for EMD to adsorb
to the surface of CaP particles and to determine the effect of
EMD on downstream cellular pathways such as adhesion,
proliferation, and differentiation of primary human osteo-
blasts and periodontal ligament (PDL) cells.
Materials and methods EMD was adsorbed onto CaP parti-
cles and analyzed for protein adsorption patterns via scanning
electron microscopy and high-resolution immunocytochemis-
try with an anti-EMD antibody. Cell attachment and cell
proliferation were quantified using CellTiter 96 One Solution
Cell Assay (MTS). Cell differentiation was analyzed using
real-time PCR for genes encoding Runx2, alkaline phospha-
tase, osteocalcin, and collagen1α1, and mineralization was
assessed using alizarin red staining.
Results Analysis of cell attachment revealed significantly
higher number of cells attached to EMD-adsorbed CaP
particles when compared to control and blood-adsorbed
samples. EMD also significantly increased cell proliferation
at 3 and 5 days post-seeding. Moreover, there were signif-
icantly higher mRNA levels of osteoblast differentiation
markers including collagen1α1, alkaline phosphatase, and
osteocalcin in osteoblasts and PDL cells cultured on EMD-
adsorbed CaP particles at various time points.
Conclusion The present study suggests that the addition of
EMD to CaP grafting particles may influence periodontal
regeneration by stimulating PDL cell and osteoblast attach-
ment, proliferation, and differentiation. Future in vivo and
clinical studies are required to confirm these findings.
Clinical relevance The combination of EMD and CaP may
represent an option for regenerative periodontal therapy in
advanced intrabony defects.
Keywords Enamel matrix derivative (EMD) . Emdogain .
Allograft . Blood proteins . Protein adsorption . Bone
grafting materials
Introduction
Over the past 20 years, significant progress has been made in
the development of new bone grafts and bone substitute mate-
rials for the treatment of bony defects [1]. Bone grafts are
commonly used in oral surgeries to fill voids, augment bone,
facilitate or enhance bone repair, provide mechanical mem-
brane support, stabilize blood clots, and serve as a vehicle for
antibiotics and growth factors. Although autogenous bone
grafts are considered the gold standard, a variety of biological
and synthetic materials, including bone allografts (freeze dried
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from human donors), xenografts (from animals or plants), and
alloplasts (synthetically fabricated such as hydroxyapatite,
beta tricalcium phosphate, biphasic calcium phosphate,
polymers and bioactive glass), are extensively being
studied [2–5] in order to avoid the drawbacks and
limitations of autogenous bone which include donor site
morbidity and increased surgical costs.
In order to improve the osteoconductive properties of
synthetic bone grafts, recent attempts at combining
alloplasts with autogenous bone or growth factors have
been utilized to establish osteoinductive capacity [1,
6–9]. Nevertheless, the inability to harvest large quanti-
ties of autogenous bone and the large expenses and
short half-lives of growth factors still pose a clinical
challenge [10]. Yuan et al. were one of the first to show
that different synthetic biomaterials were able to induce
ectopic bone formation in various animal models, and
further studies have reconfirmed these observations [11].
Recently, a calcium phosphate (CaP) ceramic sintered at
low temperatures was implanted in dogs and sheep and
demonstrated as effective as autologous bone in treating
bone defects [12, 13]. Bone induction by CaP, although
shown in some studies, is in general not the standard
mode of action for the large majority of CaP products.
Similarly, the use of an enamel matrix derivative
(EMD) composed primarily of amelogenin proteins has
successfully been utilized for its ability to regenerate
periodontal tissues including cementum, periodontal lig-
ament, and bone [14]. Although histological and con-
trolled clinical studies have provided evidence for
periodontal regeneration and substantial clinical im-
provements following the use of EMD in intrabony
defects [14], concerns have been expressed regarding
the viscous nature of EMD, which may not be sufficient
to prevent flap collapse in periodontal defects with a
complicated anatomy thus limiting the amount of space
available for periodontal regeneration [15, 16]. In order
to overcome this potential limitation and improve the
clinical results obtained with EMD, recent attempts at
combining various types of grafting materials with EMD
have been investigated [5, 17–30]. While the majority
of clinical [17, 21, 22, 25–28] and animal studies [20,
23, 24] reveal a potential benefit for a combination
approach, others have failed to demonstrate an advan-
tage [5, 18, 19, 29, 30].
Therefore, the aim of the present study was to assess
the ability for a particular CaP bone ceramic to support
osteoblast and periodontal ligament (PDL) cell attach-
ment, proliferation, and differentiation on their surfaces.
Furthermore, the ability for EMD to adsorb to the
surface of CaP particles as well as influence cell behav-




Scanning electron microscopy (SEM) was used to visualize
the surface topographies of CaP particles (Institut
Straumann AG, Basel, Switzerland) adsorbed with blood
and EMD (Emdogain, Institut Straumann AG, Basel,
Switzerland) or left unaltered (control). CaP particles
were fixed in 1 % glutaraldehyde and 1 % formalde-
hyde. Following dehydration with ethanol, samples were
critical point dried (Type M.9202, Critical Point Dryer, Roth
& Co., Hatfield, PA, USA) followed by overnight drying.
Next, samples were sputter coated (DCM-010, Balzers, Liech-
tenstein) with a 10-nm layer of gold and analyzed microscop-
ically using a scanning electron microscope (XL30 FEG,
Philips, Eindhoven, Netherlands) to determine surface varia-
tions between samples.
Histologic processing
In order to determine the ability for EMD to adsorb and
penetrate into CaP particles, CaP particles + EMD were
fixed in 1 % glutaraldehyde and 1 % formaldehyde,
buffered with 0.08 M sodium cacodylate (pH 7.4). The
samples were then washed in 0.1 M sodium cacodylate
buffer containing 5 % sucrose, pH 7.3, and processed
for embedding in LR White resin (Fluka, Buchs, Swit-
zerland). Semithin LR White survey sections (1 μm
thick) were cut with glass and diamond knives on a
Reichert Ultracut E microtome (Leica Microsystems,
Glattbrugg, Switzerland), stained with toluidine blue
and basic fuchsin, and observed in a Zeiss Axioplan
microscope (Carl Zeiss, Gottingen, Germany).
High-resolution immunocytochemistry
The high-resolution protein A-gold technique was used
for the immunocytochemical localization of EMD to
determine the ability for EMD to adsorb the surface
and penetrate CaP particles as previously described
[31]. Thin (80–100 nm) sections of LR White-
embedded tissues were cut with a diamond knife,
mounted on formvar- and carbon-coated nickel grids,
and then floated on a drop of 0.01 M phosphate-
buffered saline (PBS), pH 7.3, containing 1 % ovalbu-
min (Fluka, Buchs, Switzerland) in order to saturate
nonspecific binding sites. Sections were transferred and
incubated for 1 h on a drop of affinity-purified rabbit
anti-EMD polyclonal antibody [31] diluted with PBS.
Following incubation with the primary antibody, the
grids were rinsed with PBS, floated on 1 % ovalbumin
in PBS for 10 min, and then incubated for 30 min with
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protein A-gold complex prepared with gold particles of
approximately 10 nm (Drs. G Posthuma and J.W. Slots,
University Medical Center Utrecht, Utrecht, Nether-
lands). Thereafter, the grids were washed with PBS
and distilled water, contrasted with uranyl acetate and
lead citrate, and examined in a Philips 300 transmission
electron microscope operated at an accelerating voltage
of 60 kV.
EMD adsorption to bone grafting particles for in vitro
experiments
EMD was prepared according to Institut Straumann AG
standard operating protocols as previously described
[31]. Thirty milligrams of EMD was dissolved in 3 ml
of sterile 0.1 % acetic acid at 4 °C. For experiments,
stock EMD was diluted 100× in 0.1 M carbonate buffer
at 4 °C to a working concentration of 100 μg/ml. One
milliliter of EMD solution was incubated overnight at
4 °C into 24-well culture dishes containing 100mg of CaP
particles (Institut Straumann, AG, Basel, Switzerland).
Following incubation, dishes were rinsed twice with 1 ml
PBS.
Osteoblast and PDL cell isolation and differentiation
Human bone chips were cultured according to an ex-
plant model under a protocol approved by the Ethics
Committee, Katon Bern, Switzerland. PDL cells were
obtained from the middle third portion of three teeth
extracted from healthy patients with no signs of peri-
odontal diseases at the Department of Orthodontics,
Dental Clinic, University of Bern, as previously de-
scribed [31]. Primary human osteoblasts and PDL cells
were detached from the tissue culture plastic using
trypsin solution (Invitrogen, Basel, Switzerland). Cells
used for experimental seeding were from passages 4–6.
Primary osteoblasts and PDL cells were separately seed-
ed at a density of 10,000 cells into their respective 24-
well culture plates for cell attachment and cell prolifer-
ation experiments and 50,000 cells for real-time PCR
and alizarin red experiments. For experiments lasting
longer than 5 days, the medium was replaced twice
weekly.
Adhesion and proliferation assays
Primary osteoblasts and PDL cells were quantified using
the CellTiter 96 One Solution Cell Assay (MTS;
Promega, Madison, WI, USA) as previously described
[32]. Cells were seeded on 100 mg of CaP per well in
24-well plates at a density of 10,000 cells per well. At
4 and 8 h for cell adhesion and 1, 2, 3, and 5 days for
cell proliferation, cells were washed with PBS incubated
with 80 μl of CellTiter96 aqueous solution dissolved in
400 μl of PBS. After 4 h of culture, the cell viability
was determined by measuring the absorbance at 490 nm
on a 96-well plate reader. Experiments were performed
in triplicate with three independent experiments for each
condition. Data (±SE) were normalized to control
samples.
Real-time RT-PCR
Real-time RT-PCR was employed to quantify the total
RNA of PDL cell and osteoblast-related differentiation
markers. Total RNA was isolated using TRIZOL reagent
and RNAeasy Mini kit (Qiagen, Basel, Switzerland) at
3, 7, and 14 days of osteoblast differentiation markers.
Primer and probe sequences for genes encoding alkaline
phosphatase (ALP, Hs01029144_m1), runt-related tran-
scription factor 2 (Runx2, Hs00231692_m1), collagen1α1
(COL1A1, Hs01028970_m1) , os teoca lc in (OC,
Hs01587814_g1), and glyceraldehyde 3-phosphate dehydro-
genase (GAPDH, Hs03929097_g1) were purchased as
predesigned gene expression assays (Taqman, Applied
Biosystems, Rotkreuz, Switzerland). Real-time RT-PCR
was performed using 20 μl final reaction volume of
One step Master Mix kit as previously described [33].
RNA quantification was performed using a Nanodrop
2000c, and 100 ng of total RNA was used per sample
well. All samples were assayed in triplicate, and three
independent experiments were performed. The ΔΔCt
method was used to calculate gene expression levels
normalized to GAPDH values and calibrated to control
CaP particles. Data were log-transformed prior to anal-
ysis by two-way ANOVA with Bonferroni test using
Graphpad Software v. 4 (La Jolla, CA, USA).
Alizarin red quantification
Alizarin red staining was performed to determine the pres-
ence of extracellular matrix mineralization after 21 days.
Osteoblasts were seeded at a density of 50,000 cells per
24-well culture dish onto control, blood-adsorbed, and
EMD-adsorbed CaP particles. After 21 days, cells were
fixed in 96 % ethanol for 15 min and stained with 0.2 %
alizarin red solution (Sigma-Aldrich, Basel, Switzerland) in
water (pH 6.4) at room temperature for 1 h. Samples
representing background staining (CaP particles without
cells) were treated identically. Alizarin red was dissolved
using a solution of 20 % methanol and 10 % acetic acid
in water for 15 min. Liquid was then transferred to
cuvettes and read on a spectrophotometer at a wave-
length of 450 nm as previously described [34]. After
subtraction of background, absorbance values were
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normalized to DNA content. Data were analyzed for
statistical significance using one-way analysis of vari-
ance with Tukey’s test.
Results
Scanning electron microscopy
Control CaP particles varied in micro and macro topogra-
phies on the surface of grafting particles with the odd
interconnected pore observed within a graft particle
(Fig. 1(A, B)). The high-resolution SEM images demon-
strated an extremely rough surface with many variations
in surface nanotopographies (Fig. 1(C)). Surface adsorp-
tion with blood revealed strong attachment of red blood
cells (RBCs) and a fibrin matrix to the surface of CaP
particles (Fig. 1(D)). The accumulation of hundreds of
RBCs can be observed at magnification ×200 (Fig. 1(E)).
Interestingly, RBCs demonstrate variable affinity to the sur-
face of CaP particles with certain graft regions being prefer-
entially covered (Fig. 1(E)). At high magnification
(×6,400), a fibrin/protein network surrounding RBCs
could be observed with many of the nanotopographies
present in the control sample no longer visible (Fig. 1
(F)). The effect of surface adsorption with EMD re-
vealed substantial protein deposition on the surface of
CaP particles (Fig. 1(G)). Despite widespread protein
attachment, inhomogeneity of EMD adsorption was ob-
served (Fig. 1(H)). High-resolution images revealed a
network of EMD protein fibers spanning over the sur-
face of CaP particles with variable protein density cov-
ering the surface (Fig. 1(I)).
Fig. 2 TEM images demonstrating adsorption of EMD to CaP parti-
cles to the exterior of grafting material. a Particles were extensively
labeled with an anti-EMD antibody with staining observed around the
grafting particles. Little to no penetration was observed in the interior
of CaP particles (bar=0.5 μm). b No labeling was observed on control
CaP particles that were not treated with EMD
Fig. 1 SEM images of CaP
particles. (A–C) Control CaP
particles. (D–F) Adsorption of
blood to CaP particles. (G–I)
Adsorption of EMD to CaP
particles
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Transmission electron microscopy
High-resolution immunohistochemistry was then performed
using gold labeling for an anti-EMD antibody to determine
the ability for EMD to adsorb and penetrate into CaP
grafting particles (Fig. 2). CaP particles pre-adsorbed with
EMD stained positively for anti-EMD at the surface of CaP
particles. Gold labeling was rarely present on the interior of
CaP particles demonstrating an inability for EMD proteins
to penetrate to the interior regions of grafting particles.
Osteoblast and PDL cell attachment and proliferation
In order to demonstrate cell compatibility with CaP parti-
cles, primary human osteoblasts and PDL cells were ob-
served via SEM 24 h following post-seeding (Fig. 3).
Osteoblasts and PDL cells attached on all control, blood-
adsorbed, and EMD-adsorbed CAP particles (Fig. 3). Cells
seeded on EMD initially demonstrated a greater ability to
attach and spread on CaP grafting particles (Fig. 3(E,
F)). Analysis of MTS cell number revealed significantly
higher osteoblast and PDL cell number at 4 and 8 h
post-seeding on EMD-adsorbed CaP particles when
compared to blood-adsorbed and control surfaces
(Fig. 4a, b). At 24 h post-seeding, cell number
approached 100 % cell attachment levels for all treat-
ment modalities (Fig. 4a, b). EMD displayed a signifi-
cant increase on cell proliferation for both PDL cells
(Fig. 5c) and osteoblasts (Fig. 5d) at 3 and 5 days post-
seeding. Interestingly, EMD had a more pronounced
effect on PDL cells at 3 and 5 days when compared
to osteoblasts at equivalent time points (p<0.05).
Fig. 4 PDL cell and osteoblast
attachment and proliferation




PDL cell (a) and osteoblast
(b) attachment when compared
to blood-adsorbed and control
samples. EMD significantly
increased primary human PDL
cell (c) and osteoblast
(d) proliferation at 3 and 5 days
post-seeding. Data are
means±SE. n=9 samples from
three independent experiments
(p<0.05)
Fig. 3 SEM images of primary human osteoblasts (A, C, E) and PDL
cells (B, D, F) on CaP particles 8 h post-seeding. All cells attached well
on control, blood-adsorbed, and EMD-adsorbed CaP particles
Clin Oral Invest (2014) 18:443–451 447
Fig. 5 mRNA levels of osteoblast differentiation markers alkaline
phosphatase (ALP) (a–b), COL1A1 (c–d), Runx2 (e–f), and
osteocalcin (OC) (g–h) for both PDL cells and osteoblasts. EMD
significantly influenced differentiation factors at various time points.
Data shown are the average value from three independent experiments
(three replicates per experiment)±SE (*p<0.05)
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Osteoblast differentiation
Primary human osteoblasts and PDL cells were assessed for
ALP, COL1A1, Runx2, and OC gene expression at time
points 3, 7, and 14 days (Fig. 5). ALP levels were significantly
higher on EMD-adsorbed CaP particles at 7 and 14 days post-
seeding for osteoblasts (Fig. 5a) and PDL cells (Fig. 5b).
COL1A1 mRNA levels demonstrated higher, nonsignificant
expression at all time points for osteoblast and PDL cells
seeded on EMD-adsorbed CaP particles when compared to
control and blood-adsorbed samples (Fig. 5c, d). Analysis of
Runx2 gene expression showed significant increases in
mRNA levels at both 7 and 14 days post-seeding for PDL
cells seeded on EMD when compared to control and blood-
adsorbed CaP particles (Fig. 5f). No significant differences
were observed for Runx2 gene expression in osteoblasts
(Fig. 5e). OC mRNA levels showed significant increases for
both PDL cells and osteoblasts seeded on EMD-adsorbed CaP
particles at 7 and 14 days post-seeding when compared to
control and blood-adsorbed particles (Fig. 5g, h). In order to
further determine the effects of EMD on osteoblast differenti-
ation, mineralization was assessed via alizarin red staining. At
21 days post-seeding, EMD significantly increased alizarin
red staining when compared to control and blood-adsorbed
particles (Fig. 6).
Discussion
It was recently demonstrated that a biphasic calcium phos-
phate sintered at a relatively low temperature has a high
ability to promote ectopic bone formation when compared
to other synthetic grafting particles [35]. Two main material
factors, microporosity and dissolution rate, are suggested to
be the reason for the different abilities for synthetic bone
grafts to induce ectopic bone formation [35]. The induction
of bone formation by CaP ceramics is thought to be con-
trolled via a secondary mechanism by which CaP grafts
have a high affinity for proteins including bone morphoge-
netic proteins which are then able to induce bone formation.
In the present study, we tested the ability for CaP bone
grafts to adsorb enamel matrix proteins. EMD is a widely
used biologic agent capable of enhancing periodontal wound
healing/regeneration [14]. The in vitro roles have been well
documented in both osteoblasts and PDL cells [36]. EMD has
a significant influence on cell adhesion, cell proliferation, and
cell differentiation of many cell types by mediating cell at-
tachment, spreading, proliferation, and survival as well as
expression of transcription factors, growth factors, cytokines,
extracellular matrix constituents, and other molecules in-
volved in the regulation of bone remodeling [36, 37]. In the
present study, it was determined by SEM that EMD readily
adsorbed to the surface of CaP grafting particles and that the
protein was readily observed via TEM when an anti-EMD
antibody was utilized (Fig. 2a). These results are comparable
to those described by Gestrelius et al. who demonstrated that
EMD forms insoluble spherical complexes on the surfaces of
hydroxyapatite, collagen, and denuded root surfaces [38].
Because CaP are dense grafting [1] particles, little to no
EMD was able to penetrate the interior of these grafting
materials. In contrast, we have previously demonstrated that
EMD adsorbed onto a natural bone mineral (NBM) was able
to adsorb and penetrate into the innermost regions of NBM
particles [31]. The ability for EMD adsorption to the inner-
most regions of a grafting particle to influence cell behavior
remains uninvestigated. Further research is also necessary to
evaluate the impact of higher/lower macro and micro surface
porosity on protein adsorption of EMD and how this may
affect downstream cellular pathways.
Following confirmation of protein adsorption of EMD to
the surface of the CaP grafting material, we then sought to
determine the cellular behavior of osteoblast and PDL cells
seeded on CaP particles in the presence or absence of EMD
and blood. The major component of EMD, amelogenins, is a
family of hydrophobic proteins that account for more than
90 % of the total protein content and has previously been
described as a cell adhesion molecule [38]. Several reports
have confirmed that other molecules contained in EMD
contain integrin-binding regions by demonstrating that
PDL cells attach to BSP-like molecules contained in EMD
through αvβ3 integrins [39]. In this study, EMD was able to
significantly increase PDL cell and osteoblast attachment to
CaP particles at early time points of 4 and 8 h post-seeding.
Furthermore, EMD had a significant influence on cell pro-
liferation and differentiation for both PDL cells and osteo-
blasts (Fig. 4). Interestingly, higher increases in cell
proliferation and differentiation were observed in PDL cells
when compared to osteoblasts. These findings are in accor-
dance with Dean et al. who suggested that EMD increases
Fig. 6 Alizarin red staining of primary human osteoblasts seeded on
control, blood-adsorbed, and EMD-adsorbed CaP particles. EMD sig-
nificantly increased osteoblast mineralization 21 days post-seeding.
Data shown are the average value from three independent experiments
(three replicates per experiment)±SE (*p<0.05)
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cell differentiation of mesenchymal cells early in their dif-
ferentiation process when compared to a more differentiated
cell type [40]. Since enamel matrix proteins are embryolog-
ically utilized to differentiate cells early in their maturation
states prior to root formation, it is logical to assume that EMD
as an enamel extract would also have a similar effect on cells
with a higher proportion of undifferentiated progenitor cells.
Although previous clinical and animal studies have dem-
onstrated variability among treatment with a combination of
grafting particle and EMD, under the present in vitro con-
ditions, EMD was able to stimulate PDL cell and osteoblast
attachment, proliferation, and differentiation. Future in vivo
and clinical studies are necessary to further elucidate the
effects of this combination approach for clinical use.
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